Covaxin booster dose increases immune response by 40 times

Hyderabad (Telangana) [India], July 20 (ANI): Hyderabad-based Bharat Biotech on Wednesday announced that the...

Covaxin safe for children aged 2-18 years, says Bharat Biotech

Hyderabad (Telangana) [India], June 17 (ANI): Bharat Biotech International Limited (BBIL) on Thursday announced that...

FDA removes clinical hold on phase 2,3 clinical trial for COVAXIN

Malvern (Pennsylvania) [US], May 23 (ANI): Biotechnology company Ocugen on Monday announced that the US Food and...

Covaxin found to be safe, immunogenic in 2-18 age group in...

Hyderabad (Telangana) [India], December 30 (ANI): Hyderabad based vaccine manufacturer Bharat Biotech on Thursday...

Lancet Infectious Diseases study compare well with phase 3...

New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness...

Covaxin 50 pc effective against symptomatic COVID: Lancet study

New Delhi [India], November 24 (ANI): Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective...

No serious adverse effect due to the COVAXIN vaccine reveals...

New Delhi [India], December 16 (ANI): No serious adverse effect related to the vaccine has been reported by...